Using the “proportion of patients covered” and the Kaplan‐Meier survival analysis to describe treatment persistence

Pharmacoepidemiology and Drug Safety, EarlyView.

https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.4582?af=R

Source: Pharmacoepidemiology and Drug Safety - June 28, 2018 Category: Drugs & Pharmacology Authors: LotteRasmussen , NicolePratt , Morten RixHansen , JesperHallas , AntonPotteg ård Source Type: research

More News: Drugs & Pharmacology